Drug price increases restrictions elimination provision and sale or distribution withdraw notice requirement elimination provision

This bill removes state restrictions on drug price increases and eliminates the requirement for manufacturers to provide notice when withdrawing a drug from sale or distribution. It repeals several existing statutes that previously allowed the state to challenge excessive drug pricing and required advance notification for drug removals. The legislation also updates rules governing the Minnesota Board of Pharmacy by removing specific language related to attorney general determinations on excessive generic drug prices from the board's review considerations. These changes affect pharmaceutical manufacturers, pharmacies, and the state's regulatory oversight of drug pricing and availability.